Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,478
archived clinical trials in
Smoking Cessation

Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Status: Enrolling
Updated:  8/15/2013
Clinical and Translational Sciences Institute
mi
from
Minneapolis, MN
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Status: Enrolling
Updated: 8/15/2013
Clinical and Translational Sciences Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Enhancing a High School Based Smoking Cessation Program
Contingency Management for Smoking Cessation in Adolescent Smokers - Phase IV, Enhancing a High School Based Smoking Cessation Program
Status: Enrolling
Updated:  8/19/2013
CMHC
mi
from
New Haven, CT
Enhancing a High School Based Smoking Cessation Program
Contingency Management for Smoking Cessation in Adolescent Smokers - Phase IV, Enhancing a High School Based Smoking Cessation Program
Status: Enrolling
Updated: 8/19/2013
CMHC
mi
from
New Haven, CT
Click here to add this to my saved trials
Smoking Cessation in Rural Hospitals
Centralized Disease Management for Rural Hospitalized Smokers
Status: Enrolling
Updated:  8/29/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Smoking Cessation in Rural Hospitals
Centralized Disease Management for Rural Hospitalized Smokers
Status: Enrolling
Updated: 8/29/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers
Effects of Sulforaphane (SFN)on Innate Immune Responses to Live Attenuated Influenza Virus in Smokers and Nonsmokers
Status: Enrolling
Updated:  9/6/2013
UNC Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers
Effects of Sulforaphane (SFN)on Innate Immune Responses to Live Attenuated Influenza Virus in Smokers and Nonsmokers
Status: Enrolling
Updated: 9/6/2013
UNC Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
PATH Partnering to Achieve Tobacco-free Health
Acceptance & Commitment Therapy for Smoking Cessation (Aka PATH Study - Partnering to Achieve Tobacco-free Health)
Status: Enrolling
Updated:  9/12/2013
Group Health Cooperative
mi
from
Seattle, WA
PATH Partnering to Achieve Tobacco-free Health
Acceptance & Commitment Therapy for Smoking Cessation (Aka PATH Study - Partnering to Achieve Tobacco-free Health)
Status: Enrolling
Updated: 9/12/2013
Group Health Cooperative
mi
from
Seattle, WA
Click here to add this to my saved trials
Tobacco Use Among Arab American Youth
Arab American Youth: Tobacco Use and Intervention
Status: Enrolling
Updated:  10/8/2013
Arab American Center for Economic & Social Services
mi
from
Dearborn, MI
Tobacco Use Among Arab American Youth
Arab American Youth: Tobacco Use and Intervention
Status: Enrolling
Updated: 10/8/2013
Arab American Center for Economic & Social Services
mi
from
Dearborn, MI
Click here to add this to my saved trials
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use
Status: Enrolling
Updated:  10/17/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use
Status: Enrolling
Updated: 10/17/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use
Status: Enrolling
Updated:  10/17/2013
Oregon Research Institute
mi
from
Eugene, OR
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use
Status: Enrolling
Updated: 10/17/2013
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated:  10/28/2013
McLean Hospital
mi
from
Belmont, MA
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated: 10/28/2013
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated:  10/28/2013
Massachusetts General Hospital
mi
from
Boston, MA
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated: 10/28/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated:  10/28/2013
Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging
mi
from
Charlestown, MA
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers
Status: Enrolling
Updated: 10/28/2013
Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging
mi
from
Charlestown, MA
Click here to add this to my saved trials
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)
A Single-center, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of THS 2.2 Menthol Following Single Use in Smokers Compared to Menthol Conventional Cigarettes and Nicotine Nasal Spray
Status: Enrolling
Updated:  10/28/2013
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)
A Single-center, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of THS 2.2 Menthol Following Single Use in Smokers Compared to Menthol Conventional Cigarettes and Nicotine Nasal Spray
Status: Enrolling
Updated: 10/28/2013
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluation of Cessation Preferences of Menthol Smokers
Evaluation of Cessation Preferences of Menthol Smokers
Status: Enrolling
Updated:  10/31/2013
University of Minnesota, Delaware Clinical Research Unit
mi
from
Minneapolis, MN
Evaluation of Cessation Preferences of Menthol Smokers
Evaluation of Cessation Preferences of Menthol Smokers
Status: Enrolling
Updated: 10/31/2013
University of Minnesota, Delaware Clinical Research Unit
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pioglitazone for Heroin and for Nicotine Dependence
Effects of Pioglitazone, a PPARγ Agonist, on the Abuse Liability of Heroin and of Nicotine
Status: Enrolling
Updated:  11/4/2013
New York State Psychiatric Institute
mi
from
New York, NY
Pioglitazone for Heroin and for Nicotine Dependence
Effects of Pioglitazone, a PPARγ Agonist, on the Abuse Liability of Heroin and of Nicotine
Status: Enrolling
Updated: 11/4/2013
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of An Oral Fluid Collection Device
Collection and Testing of Human Oral Fluid Samples/VioOne OF Sample Collection Device
Status: Enrolling
Updated:  12/31/2013
Avioq
mi
from
Research Triangle Park, NC
Evaluation of An Oral Fluid Collection Device
Collection and Testing of Human Oral Fluid Samples/VioOne OF Sample Collection Device
Status: Enrolling
Updated: 12/31/2013
Avioq
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
Status: Enrolling
Updated:  2/24/2014
University of Connecticut Health Center
mi
from
Farmington, CT
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
Status: Enrolling
Updated: 2/24/2014
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
Mobile Application Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
Status: Enrolling
Updated:  2/27/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
Mobile Application Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
Status: Enrolling
Updated: 2/27/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
Status: Enrolling
Updated:  3/6/2014
Yale-New Haven Hospital
mi
from
New Haven, CT
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
Status: Enrolling
Updated: 3/6/2014
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Support Person Intervention to Promote a Smoking Helpline
Support Person Effectiveness Study to Promote Smoker Utilization of the QUITPLAN Helpline
Status: Enrolling
Updated:  3/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Support Person Intervention to Promote a Smoking Helpline
Support Person Effectiveness Study to Promote Smoker Utilization of the QUITPLAN Helpline
Status: Enrolling
Updated: 3/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
Topiramate to Aid Smoking Cessation in Recovering Alcohol Dependent Men
Status: Enrolling
Updated:  3/18/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
Topiramate to Aid Smoking Cessation in Recovering Alcohol Dependent Men
Status: Enrolling
Updated: 3/18/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
Mobile Sensing of Smoking Behavior
Mobile Sensing of Smoking Behavior
Status: Enrolling
Updated:  4/15/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Mobile Sensing of Smoking Behavior
Mobile Sensing of Smoking Behavior
Status: Enrolling
Updated: 4/15/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Motivating Smokers With Mobility Impairments to Quit Smoking
Motivating Smokers With Mobility Impairments to Quit Smoking
Status: Enrolling
Updated:  4/30/2014
Miriam Hospital
mi
from
Providence, RI
Motivating Smokers With Mobility Impairments to Quit Smoking
Motivating Smokers With Mobility Impairments to Quit Smoking
Status: Enrolling
Updated: 4/30/2014
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Testing Methods of Self-persuasion Involving Cigarette Smoking
Testing Methods of Self-persuasion Involving Cigarette Smoking
Status: Enrolling
Updated:  5/12/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Testing Methods of Self-persuasion Involving Cigarette Smoking
Testing Methods of Self-persuasion Involving Cigarette Smoking
Status: Enrolling
Updated: 5/12/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Mindfulness Based Application for Smoking Cessation
A Mindfulness Based Application for Smoking Cessation
Status: Enrolling
Updated:  5/22/2014
University of Virginia
mi
from
Charlottesville, VA
A Mindfulness Based Application for Smoking Cessation
A Mindfulness Based Application for Smoking Cessation
Status: Enrolling
Updated: 5/22/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated:  6/3/2014
The University of California, San Diego
mi
from
La Jolla, CA
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated: 6/3/2014
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated:  6/3/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated: 6/3/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated:  6/3/2014
University of Virginia Center for Addiction Research and Education
mi
from
Charlottesville, VA
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated: 6/3/2014
University of Virginia Center for Addiction Research and Education
mi
from
Charlottesville, VA
Click here to add this to my saved trials
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated:  6/3/2014
University of Virginia Center for Addiction Research and Education
mi
from
Richmond, VA
New Treatment for Alcohol and Nicotine Dependence
High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
Status: Enrolling
Updated: 6/3/2014
University of Virginia Center for Addiction Research and Education
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluation of Cessation Preferences of Menthol Smokers
Evaluation of Cessation Preferences of Menthol Smokers
Status: Enrolling
Updated:  6/9/2014
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Evaluation of Cessation Preferences of Menthol Smokers
Evaluation of Cessation Preferences of Menthol Smokers
Status: Enrolling
Updated: 6/9/2014
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation
A Pilot Study of Withdrawal Regulation Training vs. Relaxation Training for Smoking Cessation (Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation)
Status: Enrolling
Updated:  7/15/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation
A Pilot Study of Withdrawal Regulation Training vs. Relaxation Training for Smoking Cessation (Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation)
Status: Enrolling
Updated: 7/15/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Varenicline + Prazosin for Heavy Drinking Smokers
Pilot Trial of Varenicline and Prazosin to Treat Heavy Drinking Smokers
Status: Enrolling
Updated:  7/16/2014
Yale University School of Medicine
mi
from
New Haven, CT
Varenicline + Prazosin for Heavy Drinking Smokers
Pilot Trial of Varenicline and Prazosin to Treat Heavy Drinking Smokers
Status: Enrolling
Updated: 7/16/2014
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth: A CBPR RCT
Status: Enrolling
Updated:  8/4/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth: A CBPR RCT
Status: Enrolling
Updated: 8/4/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery
A Randomized, Double Blind, Study to Evaluate the Efficacy of Nasal Nicotine Spray to Reduce Post-Operative Opioid Requirements in Nonsmokers in Elective Laparoscopic Bariatric Surgical Patients
Status: Enrolling
Updated:  8/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery
A Randomized, Double Blind, Study to Evaluate the Efficacy of Nasal Nicotine Spray to Reduce Post-Operative Opioid Requirements in Nonsmokers in Elective Laparoscopic Bariatric Surgical Patients
Status: Enrolling
Updated: 8/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
Status: Enrolling
Updated:  10/9/2014
MS Hershey Medical Center, Penn State College of Medicine
mi
from
Hershey, PA
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
Status: Enrolling
Updated: 10/9/2014
MS Hershey Medical Center, Penn State College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
OCAST Cessation Study
Matching Brief Smoking Interventions to Stage of Change
Status: Enrolling
Updated:  12/2/2014
The Children's Hospital at OU Medical Center
mi
from
Oklahoma City, OK
OCAST Cessation Study
Matching Brief Smoking Interventions to Stage of Change
Status: Enrolling
Updated: 12/2/2014
The Children's Hospital at OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
Status: Enrolling
Updated:  1/13/2015
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
mi
from
New York, NY
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke
Status: Enrolling
Updated: 1/13/2015
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.
Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.
Status: Enrolling
Updated:  1/15/2015
DMC
mi
from
Detroit, MI
Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.
Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.
Status: Enrolling
Updated: 1/15/2015
DMC
mi
from
Detroit, MI
Click here to add this to my saved trials
Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes
A Proof-of-Concept Study to Characterize Biomarkers of Tobacco Exposure, Product Use, and Urge-to-Smoke Following Short-Term Exclusive and Dual Ad Lib Use of Electronic Cigarettes in a Controlled Clinical Setting
Status: Enrolling
Updated:  3/5/2015
Celerion
mi
from
Lincoln, NE
Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes
A Proof-of-Concept Study to Characterize Biomarkers of Tobacco Exposure, Product Use, and Urge-to-Smoke Following Short-Term Exclusive and Dual Ad Lib Use of Electronic Cigarettes in a Controlled Clinical Setting
Status: Enrolling
Updated: 3/5/2015
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Pharmacology Research Institute
mi
from
Encino, CA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Synergy Escondido
mi
from
Escondido, CA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Synergy Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Pharmacology Research Institute
mi
from
Los Alamitos, CA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Pharmacology Research Institute
mi
from
Newport Beach, CA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Dessert Valley Research
mi
from
Rancho Mirage, CA
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Dessert Valley Research
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Avail Clinical Research
mi
from
DeLand, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Meridien Research
mi
from
Lakeland, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Compass Research East
mi
from
Leesburg, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Compass Research East
mi
from
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Compass Research LLC
mi
from
Orlando, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated:  5/4/2015
Compass Research East, LLC
mi
from
Oviedo, FL
A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation
A 12-Week, Multicenter, Double-blind, Randomized, Placebo-controlled Parallel-group Phase 2 Dose Selection Study of Lorcaserin Hydrochloride, an Oral 5-HT2C Receptor Agonist for Smoking Cessation
Status: Enrolling
Updated: 5/4/2015
Compass Research East, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials